Ann: Preliminary Final Report, page-2

Profit of $1M only arrived at due to sale of Zeehan for $2M which was basically $500,000 in cash (some yet to be received and 15M Tartana shares (half yet to be received) at a questionable value of 10 cents a share. I thought I had read previously that these Tartana shares were going to be distributed to SDV shareholders but in the June 30th financials these shares are listed as non current assets for sale. Nevertheless the fortunes of SDV IMO are entirely dependent on the progress of the Optiflox business which seems to be burning far more cash than income. How, when and if this can be reversed I have my doubts. If they can't reverse this trend in the next 12 months they'll be forced to another capital raise